APPLICATION SITE HAEMATOMA

This adverse event was reported 183 times

These drugs are most commonly taken by patients reporting APPLICATION SITE HAEMATOMA:

# Drug Count
0 PEGFILGRASTIM 18
1 ASPIRIN 10
2 ASPIRIN 325 MG 10
3 ASPIRIN 81 MG 10
4 DICLOFENAC EPOLAMINE 10
5 LEVOTHYROXINE SODIUM 9
6 AMLODIPINE 8
7 LOSARTAN 8
8 NAPROXEN 8
9 NAPROXEN SODIUM 8
See all common drugs associated with APPLICATION SITE HAEMATOMA

APPLICATION SITE HAEMATOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALCOHOL SWABS 1 0.0263
1 BUPIVACAINE AND MELOXICAM 2 0.0094
2 THROMBIN HUMAN AND FIBRINOGEN 1 0.0030
3 DICLOFENAC EPOLAMINE 10 0.0023
4 ALOGLIPTIN 6 0.0018
5 MENTHOL, METHYL SALICYLATE 1 0.0017
6 PEGFILGRASTIM 18 0.0015
7 CLONIDINE TRANSDERMAL SYSTEM 3 0.0014
8 2%MENTHOL 1 0.0010
9 COUGH SUPPRESSANT 1 0.0010
See all drugs enriched for association with APPLICATION SITE HAEMATOMA

APPLICATION SITE HAEMATOMA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Blood Coagulation Factor [EPC] 1 0.0012
1 Skin Test Antigen [EPC] 1 0.0005
2 Monoamine Oxidase Inhibitor [EPC] 1 0.0003
3 Antiparasitic [EPC] 1 0.0002
4 Pediculicide [EPC] 1 0.0002
5 Provitamin D2 Compound [EPC] 6 0.0002
6 Osmotic Diuretic [EPC] 1 0.0002
7 Autologous Cellular Immunotherapy [EPC] 1 0.0002
8 Antisense Oligonucleotide [EPC] 2 0.0002
9 GLP-2 Analog [EPC] 2 0.0001
See all drug classes enriched for association with APPLICATION SITE HAEMATOMA